Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US FDA’s Congressional Education Becoming More Essential With Key Member Departures

Executive Summary

Energy and Commerce Committee Chair Cathy McMorris Rodgers’ decision not to seek reelection may mean FDA officials must orient a new chair on their activities and priorities.

You may also be interested in...

Califf Warns US FDA Could Cut Services Without Budget Increase

The FDA commissioner indicates another flat budget or continuing resolution will not fund the mandatory pay increase already in place for staff.

QALY Bill Clears House But Its Vague Ban Against ‘Similar Measures’ Unlikely To Succeed In Senate

The legislation is a ‘Trojan horse’ designed to undermine the Biden Administration’s policies on cutting drug prices, a leading Democrat claims.

US FDA Could Have Millions Of Advisors, If Not For Current Law, Califf Says

Commissioner Califf says the technology exists and the idea would allow the agency to be more nimble, but the Paperwork Reduction Act makes the process difficult.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts